Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05669534
PHASE4

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

Sponsor: University of Connecticut

View on ClinicalTrials.gov

Summary

The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the performance of four intervention components (Attention, Executive Functioning, Memory, and Information Processing) aimed at enhancing the ability of PWID on MOUD to process and utilize HIV prevention content, leading to improvements in HIV prevention information, motivation, behavioral skills, and behaviors (IMB).

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

256

Start Date

2023-03-01

Completion Date

2027-01-01

Last Updated

2025-03-27

Healthy Volunteers

No

Interventions

BEHAVIORAL

community-friendly health recovery program

Participants will receive 4 weekly 45 minute sessions HIV prevention sessions.

DRUG

Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis

Participants will be prescribed Pre-exposure prophylaxis (PrEP) is a biomedical intervention.

Locations (1)

APT Foundation

New Haven, Connecticut, United States